ATE11775T1 - 9-amino-1-hydroxy-octahydrobenzo(c)chinoline und derivate davon. - Google Patents

9-amino-1-hydroxy-octahydrobenzo(c)chinoline und derivate davon.

Info

Publication number
ATE11775T1
ATE11775T1 AT81303339T AT81303339T ATE11775T1 AT E11775 T1 ATE11775 T1 AT E11775T1 AT 81303339 T AT81303339 T AT 81303339T AT 81303339 T AT81303339 T AT 81303339T AT E11775 T1 ATE11775 T1 AT E11775T1
Authority
AT
Austria
Prior art keywords
octahydrobenzo
quinolines
hydroxy
derivatives
amino
Prior art date
Application number
AT81303339T
Other languages
German (de)
English (en)
Inventor
Michael Ross Johnson
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Application granted granted Critical
Publication of ATE11775T1 publication Critical patent/ATE11775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AT81303339T 1980-07-28 1981-07-21 9-amino-1-hydroxy-octahydrobenzo(c)chinoline und derivate davon. ATE11775T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
EP81303339A EP0045171B1 (en) 1980-07-28 1981-07-21 9-amino-1-hydroxyoctahydrobenzo(c)quinolines and derivatives thereof

Publications (1)

Publication Number Publication Date
ATE11775T1 true ATE11775T1 (de) 1985-02-15

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81303339T ATE11775T1 (de) 1980-07-28 1981-07-21 9-amino-1-hydroxy-octahydrobenzo(c)chinoline und derivate davon.

Country Status (29)

Country Link
US (1) US4309545A (en:Method)
EP (1) EP0045171B1 (en:Method)
JP (1) JPS57112372A (en:Method)
KR (1) KR850000273B1 (en:Method)
AR (1) AR230988A1 (en:Method)
AT (1) ATE11775T1 (en:Method)
AU (1) AU525944B2 (en:Method)
CA (1) CA1178274A (en:Method)
CS (1) CS228515B2 (en:Method)
DD (1) DD202012A5 (en:Method)
DE (1) DE3168891D1 (en:Method)
DK (1) DK334581A (en:Method)
EG (1) EG15535A (en:Method)
ES (1) ES8301926A1 (en:Method)
FI (1) FI812338A7 (en:Method)
GR (1) GR75283B (en:Method)
GT (1) GT198170557A (en:Method)
HU (1) HU185133B (en:Method)
IE (1) IE51426B1 (en:Method)
IL (1) IL63423A0 (en:Method)
IN (1) IN158867B (en:Method)
NO (2) NO812557L (en:Method)
NZ (1) NZ197856A (en:Method)
PH (1) PH17281A (en:Method)
PL (1) PL133928B1 (en:Method)
PT (1) PT73440B (en:Method)
SU (1) SU1217254A3 (en:Method)
YU (1) YU185181A (en:Method)
ZA (1) ZA815128B (en:Method)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
EE03523B1 (et) * 1996-01-31 2001-10-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
ATE224386T1 (de) * 1996-03-26 2002-10-15 Altana Pharma Ag Neue in 6-position substituierte phenanthridine
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
PT1000035E (pt) * 1997-07-25 2003-04-30 Altana Pharma Ag 6-fenilfenantridinas substituidas
ATE224372T1 (de) * 1997-07-25 2002-10-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
BR0009200A (pt) 1999-03-22 2001-12-26 Immugen Pharmaceuticals Inc Compostos e composições para o tratamento dedoenças associada com disfunção imune
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
AU2003214226A1 (en) * 2002-03-18 2003-10-08 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
NZ551379A (en) * 2004-05-25 2010-11-26 Othera Holding Inc Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
AU525944B2 (en) 1982-12-09
PL232331A1 (en) 1983-09-26
US4309545A (en) 1982-01-05
FI812338L (fi) 1982-01-29
ES504323A0 (es) 1982-12-16
GT198170557A (es) 1983-01-12
HU185133B (en) 1984-12-28
IL63423A0 (en) 1981-10-30
EP0045171A2 (en) 1982-02-03
PL133928B1 (en) 1985-07-31
ZA815128B (en) 1982-07-28
AR230988A1 (es) 1984-08-31
PT73440A (en) 1981-08-01
PT73440B (en) 1983-06-20
IE51426B1 (en) 1986-12-24
KR850000273B1 (ko) 1985-03-15
DE3168891D1 (en) 1985-03-28
GR75283B (en:Method) 1984-07-13
EG15535A (en) 1986-09-30
JPS57112372A (en) 1982-07-13
NO854454L (no) 1985-01-29
YU185181A (en) 1983-12-31
NZ197856A (en) 1984-10-19
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
ES8301926A1 (es) 1982-12-16
SU1217254A3 (ru) 1986-03-07
DD202012A5 (de) 1983-08-24
EP0045171B1 (en) 1985-02-13
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
IN158867B (en:Method) 1987-02-07
AU7343481A (en) 1982-05-06
PH17281A (en) 1984-07-06
NO812557L (no) 1982-01-29
EP0045171A3 (en) 1982-04-28
KR830006217A (ko) 1983-09-20
IE811686L (en) 1982-01-28

Similar Documents

Publication Publication Date Title
NL7806245A (nl) Carbostyrilderivaten.
DE3381562D1 (de) Bis-kronetherderivate und ihre verwendung.
ATE11775T1 (de) 9-amino-1-hydroxy-octahydrobenzo(c)chinoline und derivate davon.
ATE70833T1 (de) Piperazinyl-heterocyclische derivate.
FI860505L (fi) Dihydro- och tetrahydrokinolinderivat.
NO932176D0 (no) Kinolin-, naftyridin- og pyridobenzoksazinderivater
FI822555A0 (fi) Foerfarande foer framstaellning av fiberfoerstaerkt, faestbart bindemedel innehaollande ytformig produkt
NL300014I2 (nl) Chinolinederivaten en bereidingsprocessen hiervoor.
IL69311A (en) 2-substituted 4-amino-6,7-dimethoxyquinoline derivatives and pharmaceutical compositions containing them
DE3483704D1 (de) Phenylchinolinsaeure und derivate als antitumormittel.
NO821931L (no) Fremgangsmaate for fremstilling av antimikrobielle naftyridin- og kinolinforbindelser
ATE11534T1 (de) Chinolinderivate.
NO813290L (no) Nytt benzotiazinderivat og anvendelse derav for fremstilling av piroxicam
DE3481611D1 (de) Carbostyrilderivate.
DK361982A (da) Carbostyrilderivater og fremgangsmaade til fremstilling heraf
FI831537A7 (fi) Kinoliinijohdannaisia.
FI801843A7 (fi) Nya karbostyrilderivat
BR8108944A (pt) Derivados de esteres de (+)-4-substituido-indanois e inseticidas
ATE27599T1 (de) Rooperol und dessen derivate.
DE3583858D1 (de) Derivate von alcoxymethylaether und alcoxymethylester.
NO811628L (no) Fremgangsmaate for fremstilling av karbapenam- og karbapen-2-em-derivater.
NL8301960A (nl) Isochinolinederivaten.
SE8006924L (sv) Rokdetektor
SE8004425L (sv) Forfarande for modifiering av silver- och blyhaltiga aterstoder
ATE36706T1 (de) Chinolinderivate.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee